A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential
- 15 June 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (12) , 3081-3085
- https://doi.org/10.1016/j.bmcl.2005.04.021
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Adenosine receptors as potential therapeutic targetsDrug Discovery Today, 1999
- Adenosine-induced cell death: evidence for receptor-mediated signallingApoptosis, 1999
- Adenosine modulation: a novel approach to analgesia and inflammationExpert Opinion on Investigational Drugs, 1998
- Molecular Biology and Pharmacology of Recombinant Adenosine ReceptorsPublished by Springer Nature ,1998
- Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and PharmacologyThe American Journal of Cardiology, 1997
- Cloning and characterisation of the human adenosine A3 receptor geneFEBS Letters, 1996
- Adenosine receptorsNeuropharmacology, 1995
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- Functional characterization of three adenosine receptor typesBritish Journal of Pharmacology, 1993
- Molecular characterization of a human brain adenosine A2 receptorMolecular Brain Research, 1992